| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT07185256 | Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) | RECRUITING | PHASE1, PHASE2 | 2025-09 | 2030-08 | 2030-08 |
| NCT05616793 | Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) | RECRUITING | PHASE1, PHASE2 | 2023-06-15 | 2028-06-15 | 2028-06-15 |